Quinolone hybrids and their anti-cancer activities: An overview.
Anti-Cancer
Hybrid compounds
Quinolone
Structure-activity relationship
Journal
European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510
Informations de publication
Date de publication:
01 Mar 2019
01 Mar 2019
Historique:
received:
10
12
2018
revised:
07
01
2019
accepted:
08
01
2019
pubmed:
21
1
2019
medline:
22
3
2019
entrez:
21
1
2019
Statut:
ppublish
Résumé
The global pandemic of drug-sensitive cancers and the increasing threat from drug-resistant cancers make an urgent need to develop more effective anti-cancer candidates. Quinolone derivatives possess promising anti-cancer activity, and some of them have already been approved to treat cancers or under clinical trials. Hybridization of quinolone with other anti-cancer pharmacophores may provide more efficient anti-cancer candidates, so quinolone hybrids worth to be investigated. In this review, the recent advances in the development of novel quinolone hybrids as potential anti-cancer agents are highlighted, and the structure-activity relationship is also discussed to provide an insight for further development of more active quinolone hybrids.
Identifiants
pubmed: 30660827
pii: S0223-5234(19)30027-3
doi: 10.1016/j.ejmech.2019.01.017
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Quinolones
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
59-79Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.